The stumble - From pipe cleaner to bone builder

Endocrine Practice

Volumn 13, Issue 2, 2007, Pages 194-197

  Swislocki, Arthur L M ^a,b   Wexler, Jason A ^c,d  

^a VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^d WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ANIMAL; BONE; CALCINOSIS; DRUG EFFECT; HUMAN; METABOLISM; OSTEOLYSIS; PATHOLOGY; REVIEW;

ANIMALS; BONE AND BONES; BONE RESORPTION; CALCINOSIS; DIPHOSPHONATES; HUMANS;

EID: 34447343137     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.13.2.194     Document Type: Review

References (23)

1. Brown K. The history of penicillin from discovery to the drive to production. Pharm Hist (Lond). 2004;34:37-43.
2. bbc.co.uk/history. Historic Figures: Sir Isaac Newton (1643-1727). Available at: http://www.bbc.co.uk/history/historic-figures/newton-isaac.shtml. Accessed for verification September 20, 2006.
3. Fleisch H. Bisphosphonates: mechanisms of action. Endocr Rev. 1998;19:80-100.
4. Blomen LMJ. History of the bisphosphonates: discovery and history of the non-medical uses of bisphosphonates. In: Bijvoet O, Fleisch HA, Canfield RE, Russell G, eds. Bisphosphonate on Bones. Amsterdam, The Netherlands: Elsevier, 1995: 111-124.
5. Fleisch H. Bisphosphonates in Bone Disease: From the Laboratory to the Patient. New York, NY: Academic Press, 2000.
6. Rosenstein L. Process of treating water. US patent 2038316, April 21, 1936; reissue 20360, 1937; 20754, 1938. Shell Development Co., San Francisco, CA.
7. Francis MD. A brief history of etidronate (Didronel). Highlights of a symposium on diphosphonates in the management of metabolic bone disease; June 17-18, 1988; Medical College of Virginia, Williamsburg, VA.
8. Fleisch H, Bisaz S. Isolation from urine of pyrophosphate, a calcification inhibitor. Am J Physiol. 1962;203:671-675.
9. Fleisch H, Russell RG, Straumann F. Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis. Nature. 1966;212:901-903.
10. Irving JT, Schibler D, Fleisch H. Bone formation in normal and vitamin D-treated rachitic rats during the administration of polyphosphates. Proc Soc Exp Biol Med. 1966;123:332-335.
11. Irving JT, Schibler D, Fleisch H. Effect of condensed phosphates on vitamin D-induced aortic calcification in rats. Proc Soc Exp Biol Med. 1966;122:852-856.
12. Francis MD, Russell RG, Fleisch H. Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Science. 1969;165:1264-1266.
13. Fleisch H, Russell RG, Francis MD. Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo. Science. 1969;165:1262-1264.
14. Bassett CA, Donath A, Macagno F, Preisig R, Fleisch H, Francis MD. Diphosphonates in the treatment of myositis ossificans. Lancet. 1969;2:845.
15. Schenk R, Merz WA, Muhlbauer R, Russell RG, Fleisch H. Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Res. 1973;11:196-214.
16. Reynolds JJ, Murphy H, Muhlbauer RC, Morgan DB, Fleisch H. Inhibition by diphosphonates of bone resorption in mice and comparison with grey lethal osteopetrosis. Calcif Tissue Res. 1973;12:59-71.
17. Neuman WF, Neuman WM. The Chemical Dynamics of Bone Mineral. Chicago, IL: University of Chicago Press, 1958: 209.
18. Neuman WF. Aerobic glycolysis in bone in the context of membrane-compartmentalization. Calcif Tissue Res. 1977;22(Suppl):169-178.
19. Levinskas GJ, Neuman WF. The solubility of bone mineral. I. J Phys Chem. 1955;59:164-168.
20. Strates BS, Neuman WF, Levinskas GJ. The solubility of bone mineral. II. J Phys Chem. 1957;61:279-282.
21. Rodan GA. Mechanisms of action of bisphosphonates. Annu Rev Pharmacol Toxicol. 1998;38:375-388.
22. Francis MD, Centner RL. The development of diphosphonates as significant health care products. J Chem Educ. 1978;55:760-766.
23. Rodan GA, Balena R. Bisphosphonates in the treatment of metabolic bone diseases. Ann Med. 1993;25:373-378.